Shivali Gulab

Shivali Gulab

Avalia Immunotherapies

2014-2015

Affiliations

Victoria University of Wellington, New Zealand

Technologies

Therapeutic

Indication

Allergy/Asthma

Infectious Disease

Oncology

Executive Summary

View/Download

Avalia Immunotherapies – A synthetic immunotherapy platform for self-adjuvanting vaccines, with a unique mode of action, aiming to improve clinical outcomes for cancer, allergy and infectious disease.

Newsletter Signup

Corporate Supporters

Community Service Providers